Keyphrases
Herpes Simplex Virus Type 2 Infection
100%
Oligonucleotides
100%
Genital Herpes Simplex Virus
100%
Topical Therapy
100%
Immunostimulatory Sequences
100%
Herpes Simplex Virus 2 (HSV-2)
38%
Guinea pig
23%
Inoculation
15%
Viral
15%
Immune Response
7%
Replication in Vitro
7%
Survival Rate
7%
Plaque Assay
7%
Genital Herpes
7%
Viral Shedding
7%
Synthetic Oligonucleotides
7%
Disease Onset
7%
Single Administration
7%
Improved Survival
7%
Guinea pig Model
7%
Sequence Context
7%
Phosphate-buffered Saline
7%
Phosphorothioate
7%
Specific Sequences
7%
CpG Motif
7%
Antiherpetic
7%
Acyclovir
7%
Mucosal Administration
7%
Vaginal Cavity
7%
Additional Indications
7%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Herpes Simplex Virus 2
100%
Genital Herpes
100%
Oligonucleotide
100%
Disease
42%
Guinea Pig
42%
Survival Rate
14%
Guinea Pig Model
14%
Phosphate Buffered Saline
14%
Aciclovir
14%
Thiophosphate
14%
Immunology and Microbiology
Herpes Simplex Virus 2
100%
Genital Herpes
100%
Guinea Pig
42%
Nucleotide Sequence
42%
Immune Response
14%
Survival Rate
14%
Viral Shedding
14%
Guinea Pig Model
14%
Neuroscience
Herpes Simplex Virus
100%
Oligonucleotide
100%
Nucleic Acid Sequence
42%
In Vitro
14%
Phosphate Buffered Saline
14%
Aciclovir
14%
Herpes
14%